Federal Cannabis Rescheduling 2026: Schedule III Explained | The Stoner Review
By The Stoner Review | Cannabis Law | Updated August 2026
Federal Cannabis Rescheduling 2026: Medical Marijuana Moves to Schedule III
The battle for legal cannabis at the federal level just hit its most concrete shift in decades. As of August 2026, state-licensed medical marijuana and FDA-approved cannabis products sit in Schedule III of the Controlled Substances Act. Adult-use cannabis remains Schedule I. Here’s exactly where the fight stands right now.
The Big Change: Medical Cannabis Rescheduled in April 2026
On April 23, 2026, Acting Attorney General Todd Blanche signed a final order placing two categories of cannabis into Schedule III: FDA-approved drug products containing marijuana, and marijuana grown, manufactured, distributed, or dispensed under a qualifying state medical marijuana license. This followed President Trump’s December 18, 2025 Executive Order 14370.
Immediate results for medical operators:
- IRS Section 280E no longer blocks ordinary business deductions for qualifying state-licensed medical businesses
- Research barriers drop significantly
- State medical licensees gained a pathway to DEA registration
What Did Not Change
Adult-use and recreational cannabis remains Schedule I. Federal criminal penalties, interstate commerce bans, and most banking restrictions continue. Rescheduling is not legalization. Possession, distribution, and sale of non-covered cannabis still violate federal law.
The Broader Rescheduling Hearing
The DEA restarted the administrative process on the 2024 proposed rule to move all marijuana to Schedule III. Hearings ran June 29 through July 15, 2026. For the first time, the federal government itself argued in favor of broader rescheduling. Post-hearing briefs were due around mid-August 2026. The Administrative Law Judge will issue a non-binding recommendation — the final decision rests with the DEA Administrator.
|
Relax. It’s Just Weed. Always has been. Always will be. Schedule I or not. 
Relax Tee — $29.00 For the ones who never needed the government to tell them it was okay. Cannabis streetwear. Shop Now → |
Congress and Banking Access
The SAFE Banking Act of 2026 was reintroduced on a bipartisan basis in both the House and Senate in late June 2026. It would protect banks and credit unions that serve state-legal cannabis businesses. As of early August 2026 it remains in committee. No full descheduling or federal legalization bill has advanced meaningfully this session.
Why This Matters Right Now
Medical cannabis now operates under a clearer federal framework with real tax relief. Adult-use markets still face the full Schedule I conflict. The next decisive steps are the ALJ recommendation, the DEA’s final rule, the outcome of D.C. Circuit litigation, and whether Congress finally moves on banking protections.
Bottom line: Federal cannabis policy moved from stagnation to partial progress in 2026. Medical is Schedule III. Adult-use is still waiting. The fight continues.
For the full hemp side of the federal picture, read our breakdown of the federal hemp ban and Section 781 →
Related reads: NECANN NJ 2026 — Top 10 NJ Vape Carts August 2026 — Best Hash Dispensaries NJ 2026
Find more gritty, honest stories, strain reviews, travel guides, and multi-minded stoner perspectives at theStonerReview.com/blog.
Is marijuana now legal at the federal level in 2026?
No. Medical moved to Schedule III. Adult-use remains Schedule I. Federal penalties still apply to non-covered cannabis.
What does Schedule III mean for cannabis businesses?
Medical operators: 280E gone, research opens up, DEA registration pathway available. Adult-use operators: no change, still full Schedule I burden.
What is the SAFE Banking Act?
Protects banks serving state-legal cannabis businesses. Reintroduced June 2026, still in committee as of August 2026.
Will adult-use cannabis be rescheduled federally?
DEA hearings ran June 29–July 15, 2026. ALJ recommendation pending. DEA Administrator makes the final call. D.C. Circuit litigation also ongoing.
|
Free the Green. The Fight Isn’t Over. Bold, unapologetic. Built for the ones who know Schedule III is just the beginning. 
Free the Green Hoodie — $49.99 Cannabis freedom apparel. For the ones still in it for the long haul. Shop Now → Browse All Hoodies → |
Nose First, Percentage Second
Lab printouts are useful. They are not the whole story. A cut that smells loud, cured clean, and burns white will outperform a bigger THC number that tastes like cardboard. Ask for the nose. Ask who grew it. Ask what the jar smelled like when it opened — not just what the sticker claims.
At The Stoner Review we score what we actually smoke: flavor, effect shape, ash, and whether we would buy it again with our own money. That is the difference between a menu write-up and a field note.
Keep Reading on The Stoner Review
More field notes from the same smoke-stained notebook:
Find more gritty, honest stories, strain reviews, travel guides, and multi-minded stoner perspectives at theStonerReview.com/blog.
